ID23783A - Anti fungi 2.4.4.-trisubstitusi-1,3-dioksolan - Google Patents

Anti fungi 2.4.4.-trisubstitusi-1,3-dioksolan

Info

Publication number
ID23783A
ID23783A IDW20000032A ID20000032A ID23783A ID 23783 A ID23783 A ID 23783A ID W20000032 A IDW20000032 A ID W20000032A ID 20000032 A ID20000032 A ID 20000032A ID 23783 A ID23783 A ID 23783A
Authority
ID
Indonesia
Prior art keywords
aryl
6alkyl
hydrogen
independently
optionally substituted
Prior art date
Application number
IDW20000032A
Other languages
English (en)
Inventor
Lieven Meerpoel
Jan Heeres
Frank Christopher Odds
Hugo Florent A Vanden Bossche
Louis Jozef E Van Der Veken
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ID23783A publication Critical patent/ID23783A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IDW20000032A 1997-07-11 1998-07-07 Anti fungi 2.4.4.-trisubstitusi-1,3-dioksolan ID23783A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97202181 1997-07-11

Publications (1)

Publication Number Publication Date
ID23783A true ID23783A (id) 2000-05-11

Family

ID=8228553

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000032A ID23783A (id) 1997-07-11 1998-07-07 Anti fungi 2.4.4.-trisubstitusi-1,3-dioksolan

Country Status (34)

Country Link
US (1) US6387906B1 (id)
EP (1) EP1068200B1 (id)
KR (1) KR100540460B1 (id)
AP (1) AP1379A (id)
AR (1) AR015130A1 (id)
AT (1) ATE289303T1 (id)
AU (1) AU749760B2 (id)
BG (1) BG64314B1 (id)
BR (1) BRPI9811679B8 (id)
CA (1) CA2295090C (id)
CZ (1) CZ297453B6 (id)
DE (1) DE69829082T2 (id)
DK (1) DK1068200T3 (id)
EA (1) EA002828B1 (id)
EE (1) EE04155B1 (id)
ES (1) ES2238765T3 (id)
GE (1) GEP20033054B (id)
HK (1) HK1032404A1 (id)
HR (1) HRP20000007B1 (id)
HU (1) HU225159B1 (id)
ID (1) ID23783A (id)
IL (1) IL133919A (id)
MY (1) MY118844A (id)
NO (1) NO318328B1 (id)
NZ (1) NZ501982A (id)
PL (1) PL193703B1 (id)
PT (1) PT1068200E (id)
SI (1) SI1068200T1 (id)
SK (1) SK285321B6 (id)
TR (1) TR200000154T2 (id)
TW (1) TW593312B (id)
UA (1) UA71543C2 (id)
WO (1) WO1999002523A1 (id)
ZA (1) ZA986160B (id)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19945982A1 (de) 1999-09-24 2001-03-29 Knoll Ag Geschwindigkeitsbestimmte Partikel
US20040086567A1 (en) * 2002-10-30 2004-05-06 Pawan Seth Bioequivalent composition of itraconazole and a hydrophilic polymer
MX2010009732A (es) * 2008-03-03 2010-09-30 Stiefel Laboratories Procedimientos para preparar compuestos de diol y dioxolano enantiomericamente puros.
WO2010099518A2 (en) * 2009-02-27 2010-09-02 Thesis Chemistry, Llc Method for manufacture of 2-oxoimidazolidines
CN105777486B (zh) * 2016-03-30 2018-09-11 浙江大学宁波理工学院 一种2-[2-(2,4-二氟苯基)-2-丙烯-1-基]-1,3-丙二醇的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4619931A (en) 1983-02-28 1986-10-28 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles
CA1292472C (en) 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
US4788190A (en) * 1986-12-24 1988-11-29 Schering Corporation 2,4,4-tri- and 2,2,4,4-tetra substituted-1,3-dioxolane antifungal, antiallergy compounds
NZ233502A (en) 1989-06-09 1991-11-26 Janssen Pharmaceutica Nv 4-(1,2,4-triazole- or imidazole-phenyl-substituted) -1-(1,3-dioxolan-4-ylmethoxyphenyl) piperazine derivatives; preparatory processes: fungicidal and antiviral compositions
IL103558A0 (en) * 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals
SI0741737T1 (en) * 1994-01-24 2000-02-29 Janssen Pharmaceutica N.V. Watersoluble azole antifungals

Also Published As

Publication number Publication date
BG103982A (en) 2000-08-31
CZ463799A3 (cs) 2000-04-12
HRP20000007A2 (en) 2000-12-31
EE04155B1 (et) 2003-10-15
HUP0004459A3 (en) 2002-11-28
BG64314B1 (bg) 2004-09-30
DE69829082D1 (de) 2005-03-24
CZ297453B6 (cs) 2006-12-13
DK1068200T3 (da) 2005-06-20
PL193703B1 (pl) 2007-03-30
EP1068200A1 (en) 2001-01-17
IL133919A0 (en) 2001-04-30
BR9811679A (pt) 2000-09-19
CA2295090C (en) 2009-09-08
AR015130A1 (es) 2001-04-18
ES2238765T3 (es) 2005-09-01
UA71543C2 (uk) 2004-12-15
HU225159B1 (en) 2006-07-28
TW593312B (en) 2004-06-21
HUP0004459A2 (hu) 2002-04-29
SK184199A3 (en) 2000-07-11
TR200000154T2 (tr) 2000-06-21
EE200000020A (et) 2000-10-16
AU8857698A (en) 1999-02-08
EA002828B1 (ru) 2002-10-31
NO20000114D0 (no) 2000-01-10
NO20000114L (no) 2000-03-13
IL133919A (en) 2002-02-10
PL338009A1 (en) 2000-09-25
EA200000116A1 (ru) 2000-08-28
NZ501982A (en) 2000-10-27
BRPI9811679B1 (pt) 2016-10-18
WO1999002523A1 (en) 1999-01-21
EP1068200B1 (en) 2005-02-16
HRP20000007B1 (en) 2008-12-31
DE69829082T2 (de) 2005-12-29
SK285321B6 (sk) 2006-11-03
SI1068200T1 (id) 2005-08-31
GEP20033054B (en) 2003-08-25
NO318328B1 (no) 2005-03-07
KR20010020576A (ko) 2001-03-15
BRPI9811679B8 (pt) 2021-05-25
ATE289303T1 (de) 2005-03-15
US6387906B1 (en) 2002-05-14
HK1032404A1 (en) 2001-07-20
CA2295090A1 (en) 1999-01-21
MY118844A (en) 2005-01-31
ZA986160B (en) 2000-01-10
AU749760B2 (en) 2002-07-04
KR100540460B1 (ko) 2006-01-12
AP2000001730A0 (en) 2000-03-31
AP1379A (en) 2005-03-29
PT1068200E (pt) 2005-07-29

Similar Documents

Publication Publication Date Title
AP1468A (en) Hiv inhibiting pyrimidine derivatives.
NO994268D0 (no) Farnesyltransferase-inhiberende 1,8-annelerte kinolinonderivater substituert med N- eller C-bundede imidazoler
HUT74367A (en) Fungicidal alpha-aryl-substituted cyclic amide derivatives, fungicid compositions containing these as active ingredients and using thereof
BG104499A (en) Retinoic acid mimetic anilides
DE69023321D1 (de) Antipicornaviral-Pyridazinamine.
FI951555A (fi) 5H,10H-imidatso[1,2-a]indeno[1,2-e]pyratsin-4-onijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet
ES8802223A1 (es) Procedimiento para la preparacion de derivados de 2-oxi-4h-3, 1-benzoxazin-4-ona
DE69720715D1 (en) Hexahydro-pyrido (4,3-b)indolderivate als antipsychotische arzneimittel
ID23783A (id) Anti fungi 2.4.4.-trisubstitusi-1,3-dioksolan
DK0681573T3 (da) C2-taxanderivater og farmaceutiske præparater indeholdende disse
YU215190A (sh) Imidazolovi fungicidi
ES8707718A1 (es) Procedimiento para la obtencion de 1-aril-5-alcoxiiminoalquilamino-pirazoles
IS4725A (is) Afleiður amidíns og ísóþíóþvagefnis er hindra nítrítoxíðsyntasa
MY120046A (en) Angiogenesis inhibiting thiadiazolyl pyridazine derivatives.
BR9507289A (pt) Derivados de éster e carbamato de azolonas com atividade anti-heli-cobacteriana
ATE500231T1 (de) Hiv hemmende pyrimidin derivate
DE59604901D1 (de) Carbamoylcarbonsäureamide
MY118312A (en) Angiogenesis inhibiting 5- substituted- 1,2,4- thiadiazolyl derivatives
IL80524A (en) 5-amino-1-aryl-pyrazole derivatives,their preparation and herbicidal compositions containing them
TW429147B (en) Pharmaceutical composition for the treatment of CNS disorders